% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Hendriks:830498,
author = {Hendriks, Christine M. M. and Hartkamp, Jörg and Wiezorek,
Stefan and Steinkamp, Anne-Dorothee and Rossetti, Giulia and
Lüscher, Bernhard and Bolm, Carsten},
title = {{S}ulfoximines as {ATR} inhibitors: {A}nalogs of {VE}-821},
journal = {Bioorganic $\&$ medicinal chemistry letters},
volume = {27},
number = {12},
issn = {0960-894X},
address = {Amsterdam [u.a.]},
publisher = {Elsevier Science},
reportid = {FZJ-2017-04039},
pages = {2659 - 2662},
year = {2017},
abstract = {The ATM- and Rad3-related (ATR) kinases play a key role in
DNA repair processes and thus ATR is an attractive target
for cancer therapy. Here we designed and synthesized
sulfilimidoyl- and sulfoximidoyl-substituted analogs of the
sulfone VE-821, a reported ATR inhibitor. The properties of
these analogs have been investigated by calculating
physicochemical parameters and studying their potential to
specifically inhibit ATR in cells. Prolonged inhibition of
ATR by the analogs in a Burkitt lymphoma cell line resulted
in enhanced DNA damage and a substantial amount of
apoptosis. Together our findings suggest that the
sulfilimidoyl- and sulfoximidoyl-substituted analogs are
efficient ATR inhibitors.},
cin = {IAS-5 / JSC / INM-9},
ddc = {540},
cid = {I:(DE-Juel1)IAS-5-20120330 / I:(DE-Juel1)JSC-20090406 /
I:(DE-Juel1)INM-9-20140121},
pnm = {572 - (Dys-)function and Plasticity (POF3-572) / 511 -
Computational Science and Mathematical Methods (POF3-511)},
pid = {G:(DE-HGF)POF3-572 / G:(DE-HGF)POF3-511},
typ = {PUB:(DE-HGF)16},
UT = {WOS:000402472600004},
doi = {10.1016/j.bmcl.2017.04.026},
url = {https://juser.fz-juelich.de/record/830498},
}